Semaglutide Calculator & Guide

Last updated: March 2026

GLP-1 Receptor Agonist • Weight Loss & Diabetes Management

🧮 Interactive Semaglutide Dose Calculator

Your Injection Volume:

Select parameters above

📑 Table of Contents

✅ FDA Approved: Semaglutide is FDA-approved for diabetes management (Ozempic) and weight loss (Wegovy). Always consult healthcare professionals for medical advice and prescriptions.

What is Semaglutide?

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that mimics the natural hormone GLP-1. Originally developed for type 2 diabetes treatment, it has gained significant attention for its powerful weight loss effects. The medication works by slowing gastric emptying, reducing appetite, and improving insulin sensitivity.

Semaglutide represents a breakthrough in both diabetes management and obesity treatment, offering clinically proven results in multiple large-scale trials including STEP (Semaglutide Treatment Effect in People with obesity) studies.

FDA Approval & Brand Names

FDA-Approved Formulations

  • Ozempic® - Injectable, diabetes management (0.5mg, 1mg, 2mg)
  • Wegovy® - Injectable, weight management (2.4mg)
  • Rybelsus® - Oral tablets, diabetes management (3mg, 7mg, 14mg)

The FDA first approved semaglutide in 2017 for diabetes (Ozempic), followed by weight management approval in 2021 (Wegovy). This regulatory approval distinguishes semaglutide from research peptides, providing established safety and efficacy data.

How It Works

Semaglutide activates GLP-1 receptors throughout the body, producing multiple beneficial effects:

Mechanisms of Action

  • Appetite Suppression: Acts on brain receptors to reduce hunger and food cravings
  • Delayed Gastric Emptying: Slows food movement through stomach, increasing satiety
  • Insulin Enhancement: Improves insulin sensitivity and glucose-dependent insulin release
  • Glucagon Suppression: Reduces inappropriate glucose production by the liver
  • Central Nervous System: Directly affects brain areas controlling appetite and food reward

Dosing Protocols

Semaglutide dosing follows a gradual escalation protocol to minimize gastrointestinal side effects while achieving optimal therapeutic effect.

Standard Wegovy Escalation Protocol

Weeks Dose Purpose Notes
1-4 0.25mg weekly Initial tolerance Sub-therapeutic, for GI adaptation
5-8 0.5mg weekly Early therapeutic Some weight loss typically begins
9-12 1mg weekly Therapeutic range Significant weight loss expected
13-16 1.7mg weekly Higher therapeutic Optional step before maximum
17+ 2.4mg weekly Maximum approved Highest efficacy for weight loss

Ozempic Diabetes Protocol

Phase Dose Duration
Starting 0.25mg weekly 4 weeks
Maintenance 0.5mg weekly Ongoing
If needed 1mg weekly After 4+ weeks on 0.5mg

How to Reconstitute Semaglutide

Research-grade semaglutide typically comes as lyophilized powder requiring reconstitution with bacteriostatic water. Common vial sizes and reconstitution ratios:

Reconstitution Guide

  • 2mg vial + 2mL bac water = 1mg/mL concentration
  • 3mg vial + 2mL bac water = 1.5mg/mL concentration
  • 5mg vial + 2mL bac water = 2.5mg/mL concentration
  • 5mg vial + 2.5mL bac water = 2mg/mL concentration

Step-by-Step Process

  1. Allow both vial and bacteriostatic water to reach room temperature
  2. Clean vial top and bac water vial with alcohol swab
  3. Draw desired amount of bac water into syringe
  4. Inject water slowly down the side of the vial (not directly onto powder)
  5. Gently swirl (don't shake) until powder completely dissolves
  6. Solution should be clear and colorless

🧮 Use Our Calculator Above

Calculate your exact injection volume based on vial size, water amount, and target dose.

Semaglutide vs Tirzepatide vs Retatrutide

Comparing the three major GLP-1 receptor agonists for weight loss and metabolic health:

Aspect Semaglutide Tirzepatide Retatrutide
Mechanism GLP-1 receptor agonist GLP-1/GIP dual agonist GLP-1/GIP/Glucagon triple agonist
FDA Status Approved (Ozempic, Wegovy) Approved (Mounjaro, Zepbound) Phase III trials
Weight Loss 15-20% body weight 20-25% body weight 25-30% body weight (early data)
Dosing Weekly injection Weekly injection Weekly injection
Max Dose 2.4mg (Wegovy) 15mg (Zepbound) 12mg (trials)
Side Effects Moderate GI symptoms Similar to semaglutide Higher GI symptoms initially
Cost (Brand) $1,300-1,400/month $1,400-1,500/month Not yet available

Side Effects & Management

Semaglutide's most common side effects are gastrointestinal, typically occurring during dose escalation phases and often improving with time.

Common Side Effects (>5% incidence)

  • Nausea (20-44%): Most common, peaks during escalation
  • Vomiting (9-24%): Often accompanies severe nausea
  • Diarrhea (8-20%): Usually mild to moderate
  • Constipation (3-7%): Due to delayed gastric emptying
  • Abdominal pain (5-10%): Cramping or discomfort
  • Decreased appetite: Therapeutic effect, sometimes excessive

Management Strategies

Reducing GI Side Effects

  • Slow escalation: Don't rush dose increases
  • Smaller meals: Eat smaller, more frequent meals
  • Avoid fatty foods: High-fat meals worsen nausea
  • Stay hydrated: Especially important with vomiting
  • Timing: Some find evening injection reduces daytime nausea
  • Ginger: Natural anti-nausea supplement
⚠️ Serious Side Effects: Rare but serious effects include pancreatitis, gallbladder disease, kidney problems, and thyroid tumors (black box warning). Seek immediate medical attention for severe abdominal pain, persistent vomiting, or signs of pancreatitis.

Storage Guidelines

Form Temperature Duration Notes
Lyophilized powder 2-8°C (36-46°F) 2+ years Protect from light
Reconstituted solution 2-8°C (36-46°F) 4-6 weeks Use bacteriostatic water
Pre-filled pen (Ozempic/Wegovy) 2-8°C (36-46°F) Until expiration 30 days at room temp after first use

Storage Tips: Never freeze semaglutide. Keep in original packaging to protect from light. If traveling, use insulated cooling packs but avoid direct contact with ice.

Weight Loss Results

Clinical trial data demonstrates significant weight loss with semaglutide across multiple studies:

STEP Clinical Trial Results

STEP 1 (68-week study, 2.4mg semaglutide)

  • Average weight loss: 14.9% of body weight
  • ≥5% weight loss: 86.4% of participants
  • ≥10% weight loss: 69.1% of participants
  • ≥15% weight loss: 50.5% of participants
  • ≥20% weight loss: 32% of participants

Real-World Expectations

Timeframe Expected Weight Loss Notes
Month 1-2 2-5% body weight Initial response, appetite suppression
Month 3-6 8-12% body weight Steady loss phase
Month 6-12 12-18% body weight Approaching plateau
Month 12+ Maintenance phase Focus on weight maintenance

Frequently Asked Questions

How quickly does semaglutide work?

Appetite suppression typically begins within 1-2 weeks. Significant weight loss usually starts by week 4-8, with peak effects occurring around 6-12 months of treatment.

Can I stop taking semaglutide abruptly?

While there's no dangerous withdrawal syndrome, most people regain weight when stopping semaglutide. Many healthcare providers recommend gradual dose reduction and transition to lifestyle maintenance strategies.

What happens if I miss a dose?

If missed by ≤5 days, take as soon as remembered. If >5 days late, skip the missed dose and resume normal schedule. Don't double dose.

Can I drink alcohol on semaglutide?

Alcohol isn't contraindicated, but semaglutide can reduce alcohol tolerance and potentially increase nausea. Many users report decreased alcohol cravings.

Is semaglutide covered by insurance?

Coverage varies significantly. Ozempic (diabetes) has better coverage than Wegovy (weight loss). Many insurers require prior authorization and documented weight loss attempts.

How does compounded semaglutide compare to brand name?

Compounded versions may be less expensive but lack FDA oversight for consistency and purity. Quality can vary between compounding pharmacies. Brand name products have guaranteed potency and sterility.

Can semaglutide cause muscle loss?

Rapid weight loss can include muscle mass. Combining semaglutide with resistance training and adequate protein intake (0.8-1.2g/kg body weight) helps preserve lean mass during weight loss.

Is semaglutide safe long-term?

Long-term safety data extends to 2-3 years in clinical trials. The medication appears safe for extended use in most people, though long-term effects beyond 3 years require more study.

📊 Track Your Progress

Use our tracking tools to monitor weight loss, side effects, and dosing schedule.

Access Calculator →
⚠️ Medical Supervision Required: Semaglutide is a prescription medication requiring medical oversight. This guide is for educational purposes. Always consult healthcare professionals for proper medical evaluation, prescription, and monitoring.

📚 References

  1. Wilding J, Batterham R, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. PubMed
  2. Davies M, Faerch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021;397(10278):971-984. PubMed
  3. Marso SP, Bain SC, Consoli A, et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016;375(19):1834-1844. PubMed
  4. Aroda VR, Rosenstock J, Terauchi Y, et al. PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 Diabetes. Diabetes Care. 2019;42(9):1724-1732. PubMed